Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis

Por Debled, M, Houédé, N, Madranges, N, Donamaria, C, Floquet, A, Durand, M, Mauriac, Louis
Publicado em 2007

Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy

Por Houédé, N., Locker, G., Lucas, C., Parra, H. Soto, Basso, U., Spaeth, D., Tambaro, R., Basterretxea, L., Morelli, F., Theodore, C., Lusuardi, L., Lainez, N., Guillot, A., Tonini, G., Bielle, J., Del Muro, X. Garcia
Publicado no BMC Cancer (2016)

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment

Por Pouessel, D., Neuzillet, Y., Mertens, L. S., van der Heijden, M. S., de Jong, J., Sanders, J., Peters, D., Leroy, K., Manceau, A., Maille, P., Soyeux, P., Moktefi, A., Semprez, F., Vordos, D., de la Taille, A., Hurst, C. D., Tomlinson, D. C., Harnden, P., Bostrom, P. J., Mirtti, T., Horenblas, S., Loriot, Y., Houédé, N., Chevreau, C., Beuzeboc, P., Shariat, S. F., Sagalowsky, A. I., Ashfaq, R., Burger, M., Jewett, M. A. S., Zlotta, A. R., Broeks, A., Bapat, B., Knowles, M. A., Lotan, Y., van der Kwast, T. H., Culine, S., Allory, Y., van Rhijn, B. W. G.
Publicado no Ann Oncol (2016)